• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度微生物反应器阵列中的组合筛选揭示人诱导多能干细胞衍生心肌细胞增殖的诱导作用

Induction of Human iPSC-Derived Cardiomyocyte Proliferation Revealed by Combinatorial Screening in High Density Microbioreactor Arrays.

作者信息

Titmarsh Drew M, Glass Nick R, Mills Richard J, Hidalgo Alejandro, Wolvetang Ernst J, Porrello Enzo R, Hudson James E, Cooper-White Justin J

机构信息

Australian Institute for Bioengineering &Nanotechnology, The University of Queensland, St. Lucia, QLD 4072, Australia.

School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia.

出版信息

Sci Rep. 2016 Apr 21;6:24637. doi: 10.1038/srep24637.

DOI:10.1038/srep24637
PMID:27097795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4838928/
Abstract

Inducing cardiomyocyte proliferation in post-mitotic adult heart tissue is attracting significant attention as a therapeutic strategy to regenerate the heart after injury. Model animal screens have identified several candidate signalling pathways, however, it remains unclear as to what extent these pathways can be exploited, either individually or in combination, in the human system. The advent of human cardiac cells from directed differentiation of human pluripotent stem cells (hPSCs) now provides the ability to interrogate human cardiac biology in vitro, but it remains difficult with existing culture formats to simply and rapidly elucidate signalling pathway penetrance and interplay. To facilitate high-throughput combinatorial screening of candidate biologicals or factors driving relevant molecular pathways, we developed a high-density microbioreactor array (HDMA)--a microfluidic cell culture array containing 8100 culture chambers. We used HDMAs to combinatorially screen Wnt, Hedgehog, IGF and FGF pathway agonists. The Wnt activator CHIR99021 was identified as the most potent molecular inducer of human cardiomyocyte proliferation, inducing cell cycle activity marked by Ki67, and an increase in cardiomyocyte numbers compared to controls. The combination of human cardiomyocytes with the HDMA provides a versatile and rapid tool for stratifying combinations of factors for heart regeneration.

摘要

在有丝分裂后的成年心脏组织中诱导心肌细胞增殖作为损伤后心脏再生的一种治疗策略正引起广泛关注。模式动物筛选已确定了几种候选信号通路,然而,目前尚不清楚这些通路在人类系统中单独或联合应用时能在多大程度上得到利用。从人类多能干细胞(hPSC)定向分化而来的人类心脏细胞的出现,现在提供了在体外研究人类心脏生物学的能力,但以现有的培养形式,简单快速地阐明信号通路的渗透和相互作用仍然很困难。为了便于对驱动相关分子通路的候选生物制剂或因子进行高通量组合筛选,我们开发了一种高密度微生物反应器阵列(HDMA)——一种包含8100个培养室的微流控细胞培养阵列。我们使用HDMA对Wnt、Hedgehog、IGF和FGF通路激动剂进行组合筛选。Wnt激活剂CHIR99021被确定为人类心肌细胞增殖最有效的分子诱导剂,与对照组相比,它可诱导以Ki67为标志的细胞周期活性,并增加心肌细胞数量。人类心肌细胞与HDMA的结合为分层筛选心脏再生因子组合提供了一种通用且快速的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/4d979a9550c0/srep24637-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/d41ce44edd5c/srep24637-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/1408020a906c/srep24637-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/7d87e82db9b1/srep24637-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/d160f81c60ee/srep24637-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/c849df133d2d/srep24637-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/4d979a9550c0/srep24637-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/d41ce44edd5c/srep24637-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/1408020a906c/srep24637-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/7d87e82db9b1/srep24637-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/d160f81c60ee/srep24637-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/c849df133d2d/srep24637-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d2/4838928/4d979a9550c0/srep24637-f6.jpg

相似文献

1
Induction of Human iPSC-Derived Cardiomyocyte Proliferation Revealed by Combinatorial Screening in High Density Microbioreactor Arrays.高密度微生物反应器阵列中的组合筛选揭示人诱导多能干细胞衍生心肌细胞增殖的诱导作用
Sci Rep. 2016 Apr 21;6:24637. doi: 10.1038/srep24637.
2
Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.表型筛选中人类诱导多能干细胞来源的心脏祖细胞:一种转化生长因子-β1受体激酶抑制剂可诱导高效的心脏分化。
Stem Cells Transl Med. 2016 Feb;5(2):164-74. doi: 10.5966/sctm.2015-0114. Epub 2015 Dec 18.
3
High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.用于药物开发的诱导多能干细胞衍生心肌细胞的高通量生理筛选。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1717-27. doi: 10.1016/j.bbamcr.2016.03.003. Epub 2016 Mar 4.
4
Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.三维聚(ε-己内酯)纳米纤维支架通过Wnt/β-连环蛋白信号通路直接促进小鼠诱导多能干细胞向心肌细胞分化。
BMC Cell Biol. 2015 Sep 3;16:22. doi: 10.1186/s12860-015-0067-3.
5
A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.一个用于从多能干细胞大规模生产人类心肌细胞的通用且强大的集成平台。
Stem Cells Transl Med. 2015 Dec;4(12):1482-94. doi: 10.5966/sctm.2014-0275. Epub 2015 Oct 28.
6
A simple and flexible high-throughput method for the study of cardiomyocyte proliferation.一种简单灵活的高通量方法,用于研究心肌细胞增殖。
Sci Rep. 2019 Nov 4;9(1):15917. doi: 10.1038/s41598-019-52467-0.
7
Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells.人源分泌组表型筛选发现 FGF16 可诱导 iPSC 衍生的心脏祖细胞增殖。
Int J Mol Sci. 2019 Nov 30;20(23):6037. doi: 10.3390/ijms20236037.
8
In vivo monitoring of cardiomyocyte proliferation to identify chemical modifiers of heart regeneration.在体监测心肌细胞增殖,以鉴定心脏再生的化学修饰物。
Development. 2013 Feb 1;140(3):660-6. doi: 10.1242/dev.088526.
9
Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.干细胞来源的人和小鼠心肌细胞中药物诱导的功能性心脏毒性筛查:参考化合物的作用
J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):97-111. doi: 10.1016/j.vascn.2013.05.005. Epub 2013 May 20.
10
Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway.源自人类胚胎干细胞的心肌细胞增殖是通过胰岛素样生长因子/磷脂酰肌醇-3激酶/蛋白激酶B信号通路介导的。
J Mol Cell Cardiol. 2005 Dec;39(6):865-73. doi: 10.1016/j.yjmcc.2005.09.007. Epub 2005 Oct 19.

引用本文的文献

1
Glycogen synthase kinase-3 inhibition and insulin enhance proliferation and inhibit maturation of human iPSC-derived cardiomyocytes via TCF and FOXO signaling.糖原合酶激酶-3抑制和胰岛素通过TCF和FOXO信号通路增强人诱导多能干细胞衍生心肌细胞的增殖并抑制其成熟。
Stem Cell Reports. 2025 Jan 14;20(1):102371. doi: 10.1016/j.stemcr.2024.11.001. Epub 2024 Dec 5.
2
Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor.通过含有乙酰辅酶 A 羧化酶 2 抑制剂的新型培养基增强人多能干细胞衍生心肌细胞的成熟和翻译能力。
Cells. 2024 Aug 13;13(16):1339. doi: 10.3390/cells13161339.
3

本文引用的文献

1
Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine.利用心肌细胞增殖诱导促进心脏再生医学
Curr Treat Options Cardiovasc Med. 2015 Oct;17(10):404. doi: 10.1007/s11936-015-0404-z.
2
Regulatory aspects of small molecule drugs for heart regeneration.小分子药物在心脏再生中的监管方面。
Adv Drug Deliv Rev. 2016 Jan 15;96:245-52. doi: 10.1016/j.addr.2015.06.013. Epub 2015 Jul 3.
3
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.
Multi-omic analysis reveals VEGFR2, PI3K, and JNK mediate the small molecule induction of human iPSC-derived cardiomyocyte proliferation.
多组学分析揭示血管内皮生长因子受体2(VEGFR2)、磷脂酰肌醇-3-激酶(PI3K)和应激活化蛋白激酶(JNK)介导小分子诱导人诱导多能干细胞衍生心肌细胞增殖。
iScience. 2024 Jul 11;27(8):110485. doi: 10.1016/j.isci.2024.110485. eCollection 2024 Aug 16.
4
Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications.用于治疗性筛选和生物学发现应用的高通量细胞培养技术进展。
Bioeng Transl Med. 2023 Dec 4;9(3):e10627. doi: 10.1002/btm2.10627. eCollection 2024 May.
5
Drosophila CASK regulates brain size and neuronal morphogenesis, providing a genetic model of postnatal microcephaly suitable for drug discovery.果蝇 CASK 调节大脑大小和神经元形态发生,为适合药物发现的产后小头畸形提供了遗传模型。
Neural Dev. 2023 Oct 7;18(1):6. doi: 10.1186/s13064-023-00174-y.
6
Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes.人诱导多能干细胞衍生心肌细胞增殖或成熟的调控研究进展。
Stem Cell Res Ther. 2023 Aug 30;14(1):228. doi: 10.1186/s13287-023-03470-w.
7
Harnessing developmental cues for cardiomyocyte production.利用发育线索产生心肌细胞。
Development. 2023 Aug 1;150(15). doi: 10.1242/dev.201483. Epub 2023 Aug 10.
8
Nano-liter perfusion microfluidic device made entirely by two-photon polymerization for dynamic cell culture with easy cell recovery.完全由双光子聚合制作的纳升灌注微流控器件,用于具有易于细胞回收的动态细胞培养。
Sci Rep. 2023 Jan 11;13(1):562. doi: 10.1038/s41598-023-27660-x.
9
Application and prospects of high-throughput screening for neurogenesis.神经发生的高通量筛选应用及前景
World J Stem Cells. 2022 Jun 26;14(6):393-419. doi: 10.4252/wjsc.v14.i6.393.
10
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy.诱导多能干细胞衍生细胞在疾病建模、药物研发和细胞治疗中的应用。
Cells. 2022 Jun 6;11(11):1853. doi: 10.3390/cells11111853.
ERBB2 通过促进心肌细胞去分化和增殖来触发哺乳动物心脏再生。
Nat Cell Biol. 2015 May;17(5):627-38. doi: 10.1038/ncb3149. Epub 2015 Apr 6.
4
Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation.基于心肌细胞增殖与分化机制的心脏再生
Stem Cell Res. 2014 Nov;13(3 Pt B):532-41. doi: 10.1016/j.scr.2014.09.003. Epub 2014 Sep 28.
5
Chemically defined generation of human cardiomyocytes.化学定义的人类心肌细胞生成。
Nat Methods. 2014 Aug;11(8):855-60. doi: 10.1038/nmeth.2999. Epub 2014 Jun 15.
6
Microbioreactor array screening of Wnt modulators and microenvironmental factors in osteogenic differentiation of mesenchymal progenitor cells.微流控芯片筛选 Wnt 调节剂和细胞外微环境因子对间充质祖细胞成骨分化的影响。
PLoS One. 2013 Dec 23;8(12):e82931. doi: 10.1371/journal.pone.0082931. eCollection 2013.
7
Concise review: microfluidic technology platforms: poised to accelerate development and translation of stem cell-derived therapies.简明综述:微流控技术平台:有望加速干细胞衍生疗法的开发和转化。
Stem Cells Transl Med. 2014 Jan;3(1):81-90. doi: 10.5966/sctm.2013-0118. Epub 2013 Dec 5.
8
Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells.利用多能干细胞以发育阶段特异性方式鉴定诱导心肌细胞增殖的化学物质。
Circ Cardiovasc Genet. 2013 Dec;6(6):624-33. doi: 10.1161/CIRCGENETICS.113.000330. Epub 2013 Oct 18.
9
Full factorial screening of human embryonic stem cell maintenance with multiplexed microbioreactor arrays.采用多重微生物反应器阵列对人胚胎干细胞维持进行全因子筛选。
Biotechnol J. 2013 Jul;8(7):822-34. doi: 10.1002/biot.201200375.
10
Hydrogel-coated microfluidic channels for cardiomyocyte culture.水凝胶涂覆的微流控通道用于心肌细胞培养。
Lab Chip. 2013 Sep 21;13(18):3569-77. doi: 10.1039/c3lc50252j.